Fortress Biotech, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2015 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Fortress Biotech, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2024.
  • Fortress Biotech, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $16.2M, a 337% increase year-over-year.
  • Fortress Biotech, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $32.6M, a 91.6% increase year-over-year.
  • Fortress Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $32.6M, a 91.6% increase from 2023.
  • Fortress Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $17M, a 25.9% decline from 2022.
  • Fortress Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $23M, a 18% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $32.6M +$15.6M +91.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $17M -$5.96M -25.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $23M +$3.5M +18% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $19.5M +$6.04M +44.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $13.5M +$263K +1.99% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $13.2M -$1.82M -12.2% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-04-09
2018 $15M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2015 $3.3M Jan 1, 2015 Dec 31, 2015 10-K 2016-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.